2021
DOI: 10.5114/ada.2021.112284
|View full text |Cite
|
Sign up to set email alerts
|

Itraconazole as a new pharmacotherapy method in haemangiomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Of course, it is worth debating whether systemic administration of itraconazole and hydroxychloroquine resulted in the elimination of this benign tumor by inhibiting Malassezia . As a classic systemic triazole antifungal drug, itraconazole has been confirmed to inhibit angiogenesis and proliferation while leading to increased apoptosis, thus expanding its new role in the treatment of hemangioma and non-small cell lung cancer [ [9] , [10] , [11] , [12] ]. However, no inhibitory effect of itraconazole on the proliferation of keratinocytes has been found so far.…”
Section: Discussionmentioning
confidence: 99%
“…Of course, it is worth debating whether systemic administration of itraconazole and hydroxychloroquine resulted in the elimination of this benign tumor by inhibiting Malassezia . As a classic systemic triazole antifungal drug, itraconazole has been confirmed to inhibit angiogenesis and proliferation while leading to increased apoptosis, thus expanding its new role in the treatment of hemangioma and non-small cell lung cancer [ [9] , [10] , [11] , [12] ]. However, no inhibitory effect of itraconazole on the proliferation of keratinocytes has been found so far.…”
Section: Discussionmentioning
confidence: 99%